| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals, Inc. (REGN) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 57 sells. REGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 310.5K | $189.36M | - | |
| CEO | 214.5K | $130.85M | - | |
| VP | 47.8K | $29.18M | - | |
| VP | 29.5K | $18.00M | - | |
| VP | 21.7K | $13.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2022 | McCourt Marion55 | EVP Commercial | Sale+OE | 1,100 | $581.53 | $639,683.00 | -5.3% | +29.8% | +28.2% | |
| Jul 1, 2022 | McCourt Marion55 | EVP Commercial | Sale+OE | 1,100 | $587.76 | $646,536.00 | -5.3% | +16.2% | +20.7% | |
| Jun 1, 2022 | McCourt Marion55 | EVP Commercial | Sale+OE | 1,100 | $669.51 | $736,461.00 | -5.3% | -10.7% | +11.0% | |
| May 17, 2022 | Murphy Andrew J54 | EVP Research | Sale+OE | 3,543 | $663.68 | $2,351,411.44 | -0.4% | -3.6% | +12.3% | |
| May 2, 2022 | McCourt Marion55 | EVP Commercial | Sale+OE | 1,100 | $656.97 | $722,667.00 | -5.3% | -11.6% | +22.5% | |
| May 2, 2022 | Ryan Arthur F54 | Director | Sell | 100 | $650.78 | $65,078.46 | - | -11.6% | +22.5% | |
| Apr 11, 2022 | Landry Robert E52 | EVP Finance CFO | Sale+OE | 2,187 | $734.61 | $1,606,601.59 | -0.4% | -14.9% | +13.5% | |
| Apr 7, 2022 | Larosa Joseph J66 | EVP General Counsel And Secret | Sell | 5,114 | $721.10 | $3,687,705.40 | -23.2% | -17.6% | +14.8% | |
| Apr 7, 2022 | Bassler Bonnie L59 | Director | Sale+OE | 1,240 | $725.00 | $899,000.00 | -53.4% | -17.6% | +14.8% | |
| Apr 6, 2022 | Schleifer Leonard S64 | President &CEO | Sell | 7,114 | $710.05 | $5,051,269.17 | -22.1% | -15.8% | +17.0% |